WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareHealth Information Services
Best Health Information Service Stocks to Buy Now (2026)
Top health information service stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best health information service stocks to buy now. Learn More.

Industry: Health Information Servic...
OverviewZen RatingPriceValueGrowthFinancialsMomentumSentimentForecast
DividendsDue Diligence
C
Health Information Services is Zen Rated C and is the 62nd ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Market Cap
Price
Price Target
Upside/Downside
Top Analysts Upside/Downside
Consensus
Top Analysts Consensus
Analysts
Top Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
OMCL
OMNICELL INC
$1.69B$37.11$58.5057.64%Strong Buy44.79%76.23%N/AN/A
NRC
NRC HEALTH
$426.17M$18.91$26.0037.49%Buy13.45%115.29%180.48%18.10%
OPRX
OPTIMIZERX CORP
$117.66M$6.27$12.0091.39%Strong Buy5-7.42%165.78%14.67%11.37%
BTSG
BRIGHTSPRING HEALTH SERVICES INC
$14.13B$72.88$76.004.28%Strong Buy1313.49%20.28%36.77%11.72%
NUTX
NUTEX HEALTH INC
$1.02B$148.71$262.5076.52%Strong Buy22.05%62.36%46.68%16.89%
HNGE
HINGE HEALTH INC
$5.81B$75.11$87.0815.93%Strong Buy1325.82%N/A388.68%59.57%
HSTM
HEALTHSTREAM INC
$823.87M$28.20$27.00-4.26%Hold14.23%11.80%N/AN/A
PGNY
PROGYNY INC
$2.47B$31.49$33.385.99%Strong Buy88.30%27.67%45.65%28.72%
DH
DEFINITIVE HEALTHCARE CORP
$75.66M$0.72$1.68133.61%Sell4-0.89%N/A15.98%4.54%
PHR
PHREESIA INC
$655.82M$10.61$13.6929.05%Buy133.58%65.14%13.41%7.23%
HQY
HEALTHEQUITY INC
$8.44B$100.99$112.2211.12%Strong Buy95.26%27.20%24.67%15.28%
VEEV
VEEVA SYSTEMS INC
$32.74B$201.56$242.3820.25%Buy218.25%21.34%25.63%20.50%
WAY
WAYSTAR HOLDING CORP
$4.02B$20.94$32.7756.47%Strong Buy179.73%43.06%11.51%7.82%
OMDA
OMADA HEALTH INC
$1.17B$19.69$24.3623.74%Strong Buy1118.50%N/AN/AN/A
CCLD
CARECLOUD INC
$102.41M$2.41N/AN/AN/AN/A7.84%274.00%30.96%20.83%
WEAV
WEAVE COMMUNICATIONS INC
$521.95M$6.56$8.5029.57%Strong Buy214.34%N/A33.13%13.51%
TXG
10X GENOMICS INC
$6.28B$49.43$33.46-32.32%Buy115.10%N/A11.18%8.96%
GEHC
GE HEALTHCARE TECHNOLOGIES INC
$31.59B$69.94$79.9214.27%Buy134.57%11.59%25.44%7.50%
SOLV
SOLVENTUM CORP
$15.04B$86.82$85.11-1.97%Buy92.79%-1.40%29.68%10.46%
GDRX
GOODRX HOLDINGS INC
$1.07B$3.17$3.407.26%Buy54.28%92.84%39.16%12.05%
AMWL
AMERICAN WELL CORP
$163.26M$10.84$8.88-18.13%Buy4-2.30%N/AN/AN/A
HTFL
HEARTFLOW INC
$2.23B$25.83$36.5041.31%Strong Buy422.14%N/A12.78%10.61%
HCAT
HEALTH CATALYST INC
$153.70M$2.08$2.216.15%Hold6-8.61%N/A1.42%0.48%
TDOC
TELADOC HEALTH INC
$1.19B$6.58$7.4613.43%Buy141.42%N/A-6.75%-3.21%
EVH
EVOLENT HEALTH INC
$357.69M$3.18$5.8684.31%Buy921.02%N/A20.06%4.23%
SY
SO-YOUNG INTERNATIONAL INC
$183.70M$1.83N/AN/AN/AN/A242.41%N/A60.42%33.88%
DOCS
DOXIMITY INC
$3.88B$21.24$27.5529.71%Buy206.34%20.58%35.80%30.29%
MMED
MINIMED GROUP INC
$5.10B$18.15$21.2016.84%Strong Buy109.95%N/A13.50%10.53%
SPOK
SPOK HOLDINGS INC
$224.54M$10.75$14.0030.23%Hold1N/AN/A9.97%7.25%
PRVA
PRIVIA HEALTH GROUP INC
$3.01B$23.86$29.8024.90%Strong Buy510.10%49.40%N/AN/A
CERT
CERTARA INC
$1.21B$7.78$7.64-1.76%Buy72.14%N/A9.20%6.24%
SOPH
SOPHIA GENETICS SA
$394.48M$5.76$10.0073.61%Strong Buy221.99%N/AN/AN/A
TEM
TEMPUS AI INC
$7.95B$44.29$66.8250.86%Buy1120.02%N/A116.29%22.68%
ZCMD
ZHONGCHAO INC
$53.14k$1.28N/AN/AN/AN/AN/AN/AN/AN/A
CARL
CARLSMED INC
$344.16M$12.66$18.7548.10%Strong Buy438.82%N/A-32.31%-25.10%
LFMD
LIFEMD INC
$176.04M$3.64$9.50160.99%Strong Buy410.46%20.98%95.14%20.40%
BEAT
HEARTBEAM INC
$28.70M$0.52$3.70615.67%Strong Buy5N/AN/A-1,426.57%-230.56%
ONMD
ONEMEDNET CORP
$39.63M$0.73N/AN/AN/AN/AN/AN/AN/AN/A
CTEV
CLARITEV CORP
$401.99M$23.58$29.2023.83%Strong Buy54.00%N/AN/A-4.69%
WGS
GENEDX HOLDINGS CORP
$2.05B$68.96$75.409.34%Strong Buy519.39%N/A46.84%23.51%
OWLT
OWLET INC
$152.26M$5.25$10.0090.48%Strong Buy122.30%N/A153.46%37.17%
SDGR
SCHRODINGER INC
$1.15B$15.35$16.678.58%Buy38.06%N/A-0.24%-0.12%
TALK
TALKSPACE INC
$872.74M$5.21$6.7529.56%Buy319.85%215.71%61.96%51.44%
VSEE
VSEE HEALTH INC
$3.50M$0.07N/AN/AN/AN/AN/AN/A-188.21%-62.56%
EUDA
EUDA HEALTH HOLDINGS LTD
$36.97M$19.56$55.00181.26%Strong Buy1N/AN/A-72.51%179.73%
ACON
ACLARION INC
$4.97M$2.02$7.50271.29%Buy1103.44%N/A-69.90%-66.56%
BFRG
BULLFROG AI HOLDINGS INC
$10.66M$0.58N/AN/AN/AN/A684.15%N/A7.74%6.83%
ALPS
ALPS GROUP INC
$75.38M$0.45N/AN/AN/AN/AN/AN/AN/AN/A
SLP
SIMULATIONS PLUS INC
$370.11M$18.30$16.00-12.57%Hold15.44%30.43%18.81%17.09%
MGRX
MANGOCEUTICALS INC
$5.05M$0.29N/AN/AN/AN/AN/AN/AN/AN/A
HCTI
HEALTHCARE TRIANGLE INC
$2.32M$1.15N/AN/AN/AN/A44.62%N/A47.05%30.96%
MNDR
MOBILE-HEALTH NETWORK SOLUTIONS
$1.05M$1.72N/AN/AN/AN/AN/AN/AN/AN/A
1

Health Information Service Stocks FAQ

What are the best health information service stocks to buy right now in Jul 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best health information service stocks to buy right now are:

1. Omnicell (NASDAQ:OMCL)


Omnicell (NASDAQ:OMCL) is the #1 top health information service stock out of 52 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Omnicell (NASDAQ:OMCL) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: C.

Omnicell (NASDAQ:OMCL) has a Due Diligence Score of 50, which is 19 points higher than the health information service industry average of 31.

OMCL passed 16 out of 33 due diligence checks and has strong fundamentals. Omnicell has seen its stock return 24.95% over the past year, overperforming other health information service stocks by 75 percentage points.

Omnicell has an average 1 year price target of $58.50, an upside of 57.64% from Omnicell's current stock price of $37.11.

Omnicell stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Omnicell, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Nrc Health (NASDAQ:NRC)


Nrc Health (NASDAQ:NRC) is the #2 top health information service stock out of 52 with a Zen Rating of B. Stocks with a rating of B have had an average return of +17.17% per year. Learn more.

The Component Grade breakdown for Nrc Health (NASDAQ:NRC) is: Value: C, Growth: C, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: C.

Nrc Health (NASDAQ:NRC) has a Due Diligence Score of 25, which is -6 points lower than the health information service industry average of 31. Although this number is below the industry average, our proven quant model rates NRC as a "B".

NRC passed 10 out of 38 due diligence checks and has weak fundamentals. Nrc Health has seen its stock return 49.72% over the past year, overperforming other health information service stocks by 100 percentage points.

Nrc Health has an average 1 year price target of $26.00, an upside of 37.49% from Nrc Health's current stock price of $18.91.

Nrc Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Nrc Health, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Optimizerx (NASDAQ:OPRX)


Optimizerx (NASDAQ:OPRX) is the #3 top health information service stock out of 52 with a Zen Rating of B. Stocks with a rating of B have had an average return of +17.17% per year. Learn more.

The Component Grade breakdown for Optimizerx (NASDAQ:OPRX) is: Value: A, Growth: C, Momentum: F, Sentiment: B, Safety: C, Financials: B, and AI: C.

Optimizerx (NASDAQ:OPRX) has a Due Diligence Score of 47, which is 16 points higher than the health information service industry average of 31.

OPRX passed 15 out of 33 due diligence checks and has strong fundamentals. Optimizerx has seen its stock lose -50.4% over the past year.

Optimizerx has an average 1 year price target of $12.00, an upside of 91.39% from Optimizerx's current stock price of $6.27.

Optimizerx stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Optimizerx, 80% have issued a Strong Buy rating, 0% have issued a Buy, 20% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the health information service stocks with highest dividends?

Out of 4 health information service stocks that have issued dividends in the past year, the 3 health information service stocks with the highest dividend yields are:

1. Spok Holdings (NASDAQ:SPOK)


Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 11.6%, which is 8 percentage points higher than the health information service industry average of 3.86%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 201.6% indicates that its high dividend yield might not be sustainable for the long-term.

2. Nrc Health (NASDAQ:NRC)


Nrc Health (NASDAQ:NRC) has an annual dividend yield of 3.17%, which is -1 percentage points lower than the health information service industry average of 3.86%. Nrc Health's dividend payout is not stable, having dropped more than 10% four times in the last 10 years. Nrc Health's dividend has not shown consistent growth over the last 10 years.

Nrc Health's dividend payout ratio of 147.4% indicates that its dividend yield might not be sustainable for the long-term.

3. Healthstream (NASDAQ:HSTM)


Healthstream (NASDAQ:HSTM) has an annual dividend yield of 0.47%, which is -3 percentage points lower than the health information service industry average of 3.86%. Healthstream's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Healthstream's dividend has not shown consistent growth over the last 10 years.

Healthstream's dividend payout ratio of 19.1% indicates that its dividend yield is sustainable for the long-term.

Why are health information service stocks down?

Health information service stocks were down -0.18% in the last day, and up 3.87% over the last week. Mangoceuticals was the among the top losers in the health information services industry, dropping -46.84% yesterday.

Mangoceuticals shares are trading lower after the company announced that it has entered into a definitive business combination agreement with Nuclea Energy.

What are the most undervalued health information service stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued health information service stocks right now are:

1. Nutex Health (NASDAQ:NUTX)


Nutex Health (NASDAQ:NUTX) is the most undervalued health information service stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Nutex Health has a valuation score of 57, which is 42 points higher than the health information service industry average of 15. It passed 4 out of 7 valuation due diligence checks.

Nutex Health's stock has gained 77.04% in the past year. It has overperformed other stocks in the health information service industry by 128 percentage points.

2. Ge Healthcare Technologies (NASDAQ:GEHC)


Ge Healthcare Technologies (NASDAQ:GEHC) is the second most undervalued health information service stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ge Healthcare Technologies has a valuation score of 57, which is 42 points higher than the health information service industry average of 15. It passed 4 out of 7 valuation due diligence checks.

Ge Healthcare Technologies's stock has dropped -2.37% in the past year. It has overperformed other stocks in the health information service industry by 48 percentage points.

3. Goodrx Holdings (NASDAQ:GDRX)


Goodrx Holdings (NASDAQ:GDRX) is the third most undervalued health information service stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Goodrx Holdings has a valuation score of 43, which is 28 points higher than the health information service industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Goodrx Holdings's stock has dropped -35.17% in the past year. It has overperformed other stocks in the health information service industry by 15 percentage points.

Are health information service stocks a good buy now?

50% of health information service stocks rated by analysts are a strong buy right now. On average, analysts expect health information service stocks to rise by 26.91% over the next year.

2.38% of health information service stocks have a Zen Rating of A (Strong Buy), 23.81% of health information service stocks are rated B (Buy), 52.38% are rated C (Hold), 19.05% are rated D (Sell), and 2.38% are rated F (Strong Sell).

What is the average p/e ratio of the health information services industry?

The average P/E ratio of the health information services industry is 10.5x.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.